Cost effectiveness in treatment of Anorexia Nervosa

Can three new time-limited psychological (TLP) treatments for anorexia nervosa (AN) shorten treatment duration from approx. 18 months to 9 months and reduce treatment costs as compared to specialised topclinical management.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON23072

Enrollment

166

Registered

2019-11-14

Start date

2020-01-02

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

either Anorexia Nervosa or Other Specific Feeding and Eating Disorder (OSFED) – subtype ‘atypical anorexia nervosa’, according to DSM-5 criteria

Interventions

INTERVENTIONS MANTRA, SSCM and CBT-E have been evaluated, and proven to be equally effective. At present there are no theoretical or empirical grounds for allocating individual patients to one of thes

Eligibility

Inclusion criteria

Inclusion criteria: The group of eating disordered patients at the two participating centres encompasses adult (age between 18-60) patients who are referred to secondary and tertiary treatment at the participating centers, and who have either anorexia nervosa or Other Specific Feeding and Eating Disorder (OSFED) – subtype ‘atypical anorexia nervosa’, according to DSM-5 criteria. All three new TLP treatments are aimed at recovery of the eating disorder pathology. Hence, patients included in the study, will be selected on their wish to recover from their eating disorder.

Exclusion criteria

Exclusion criteria: Patients treated under a legal measure will be excluded.

Design outcomes

Primary

Measure	Time frame
Remission defined as a return to a healthy body mass index (BMI>18.5).	—

Secondary

Measure	Time frame
- Remission of eating pathology as measured with the EDE-Q at 9 months and 24 months post baseline (Fairburn & Beglin, 1994, Pennings & Wojciechowski, 2004) - Quality adjusted life year (QALY) gains cumulated over the first 12 months post baseline, as measured with the EQ-5D-5L using Dutch tariffs (Versteegh et al, 2016) and ICECAp-A-NL (H. Al-Janabi & J. Coast, 2010). - Cumulative costs (treatment costs, other health care costs, patients’ out-of-pocket costs, and costs stemming from productivity losses owing to absenteeism and presenteeism) over the full 24 months follow-up period as measured with the TiC-P (Hakkaart-van Roijen et al, 2002). - CSQ patient satisfaction	—

Measure

Time frame

- Remission of eating pathology as measured with the EDE-Q at 9 months and 24 months post baseline (Fairburn & Beglin, 1994, Pennings & Wojciechowski, 2004) - Quality adjusted life year (QALY) gains cumulated over the first 12 months post baseline, as measured with the EQ-5D-5L using Dutch tariffs (Versteegh et al, 2016) and ICECAp-A-NL (H. Al-Janabi & J. Coast, 2010). - Cumulative costs (treatment costs, other health care costs, patients’ out-of-pocket costs, and costs stemming from productivity losses owing to absenteeism and presenteeism) over the full 24 months follow-up period as measured with the TiC-P (Hakkaart-van Roijen et al, 2002). - CSQ patient satisfaction

—

Contacts

Public ContactAlberte Jansingh

Altrecht Eetstoornissen Rintveld

a.jansingh@altrecht.nl030-6965477

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)